The CE registration is a clear product-level catalyst that expands Pulsenmore's addressable market into European fertility clinics, but with no revenue guidance or commercial terms disclosed, the immediate financial impact is speculative. Monitor for partnership announcements with European fertility centers or distribution agreements that would validate the commercial pathway. The cross-filing with the 20-F annual report provides context on the company's cash position and operating history, but no new financial data was released here.
Price Chart
Executive Summary
Pulsenmore announced CE European registration (MDR) for its second product, Pulsenmore FC, a home ultrasound system for follicular monitoring during IVF/fertility preservation. This expands the company beyond prenatal care into the broader women's health market and enables marketing across Europe, following a prior commercial agreement with Clalit Health Services in Israel. The filing is a regulatory milestone but provides no financial data or revenue guidance, making the near-term stock impact uncertain for a $16M market cap company.
Key Facts
- Pulsenmore completed CE European registration (MDR) for Pulsenmore FC, its home ultrasound system for follicular monitoring during IVF and fertility preservation.
- This is the company's second product authorized in Europe and first expansion beyond prenatal care into women's health.
- The system has already received Israeli Ministry of Health approval and a commercial agreement with Clalit Health Services was signed in January 2026.
- A clinical study at Rabin Medical Center showed high agreement between home and in-clinic ultrasound scans, published in JMIR.
- The European market opportunity is supported by ESHRE data showing >1.15M assisted reproduction cycles in Europe in 2023, with >half requiring ovarian stimulation and repeated ultrasound monitoring.
- No financial terms, revenue projections, or pricing details were disclosed in the filing.
Financial Impact
No financial figures disclosed; CE registration opens European market for second product but revenue impact is unquantifiable from this filing.
Risk Factors
- No revenue or commercial terms disclosed; path to market adoption in Europe is uncertain and may require additional sales/distribution partnerships.
- Company has limited operating history and faces execution risk in scaling manufacturing, marketing, and sales across a new geography.
- Forward-looking statements highlight risks including capital requirements, regulatory compliance in new markets, and Middle East geopolitical instability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-041693 |
| Document: form6-k.htm | 0001493152-26-041693 |
| Document: 0001493152-26-041693-index-headers.html | 0001493152-26-041693 |
| Document: 0001493152-26-041693-index.html | 0001493152-26-041693 |
| Document: 0001493152-26-041693.txt | 0001493152-26-041693 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 6-K | $1.90 | awaiting T+20 | — | $1.73 (−8.95%) |
Oct 8, 2026 19d ago | SC 13G | $1.85 | awaiting T+20 | — | $1.73 (−6.49%) |
Sep 17, 2026 5w ago | 6-K | $2.42 $1.81 | ▼ −25.21% | ▼ −26.41% | $1.73 (−28.51%) |
Sep 8, 2026 7w ago | 6-K | $2.46 $2.16 | ▼ −12.20% | ▼ −13.91% | $1.73 (−29.67%) |
Sep 2, 2026 7w ago | EFFECT | $2.55 $2.22 | ▲ +12.94% | ▲ +12.86% | $1.73 (+32.16%) |
Aug 31, 2026 8w ago | 6-K | $2.62 $2.19 | ▼ −16.41% | ▼ −16.22% | $1.73 (−33.97%) |
Aug 19, 2026 9w ago | 6-K | $3.01 $2.42 | ▼ −19.60% | ▼ −18.76% | $1.73 (−42.52%) |
Aug 17, 2026 10w ago | 6-K | $2.89 $2.41 | ▼ −16.61% | ▼ −14.63% | $1.73 (−40.14%) |
Jul 13, 2026 15w ago | 6-K | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
Jul 13, 2026 15w ago | EFFECT | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers